AronovaLive! The tech behind fintech, powering instant eligibility, global credit limits and real-time operations. Read more about it here.

PORTO ITFA 2022: COMETH THE HOUR, COMETH THE CONFERENCE
Newsletters | Featured | Company News

NEWSLETTER – MAY 2023

Since our last update, things have been moving in a really interesting direction here at Aronova. We’ve mentioned before about our Tech Behind the Fintech offering – our API-driven solution to help fintechs and other platforms get to market faster to provide invoice-backed financing solutions – but this development has led us to some really […]

READ ARTICLE
Aronova - The Tech Behind the Fintech
ITFA2022 report
Company News

PORTO ITFA 2022: COMETH THE HOUR, COMETH THE CONFERENCE

In early September, I travelled to Porto for ITFA’s 48th Annual International Trade and Forfaiting Conference, an event held in high esteem across our sector.  Not only did it offer a great […]

READ ARTICLE
ITFA 2022
Company News

IDEAS AND FRESH THINKING: HOW ITFA GATHERING COULD SPARK INNOVATION AND PARTNERSHIPS

They say necessity is the mother of invention. Indeed, as proverbs go it has more than a ring of truth to it in these economically uncertain times. Just as the pandemic accelerated digital […]

READ ARTICLE

Newsletter June2022
Newsletters | Company News

NEWSLETTER – JUNE 2022

The weekend just gone marked the Queen’s platinum jubilee in the UK, and the waving and cheering crowds lining the streets were a clear sign that things really are finally returning to […]

READ ARTICLE
Newsletters | Grow | Company News

ARONOVA QUARTERLY UPDATE – OCTOBER 2021

The quarterly newsletter from our MD David Baker provides an overview on: the recovery after the pandemic instant credit limit decisions rated funding programmes Q4 forecasts and predictions Start of […]

READ ARTICLE
Newsletters | Company News

ARONOVA QUARTERLY UPDATE – JULY 2021

Nearly a year and a half on from the first real reports of the coronavirus, the glimmer of normality is finally looking like it may actually become a reality. With nearly 78 million doses given and […]

READ ARTICLE